Pediatric Dermatology

Latest News


CME Content


Washington - A series of cutaneous pharmacology studies conductedwith a selective retinoic acid metabolism inhibitor suggest this novel compoundhas the potential for treating a variety of retinoid-responsive dermatologicdiseases but with the advantage of causing less irritation compared to retinoicacid, Gerard J. Gendimenico, Ph.D., said at the Society for InvestigativeDermatology meeting.

A sweeping new proposed federal regulation dealing with hospital outpatientcompensation would change Medicare payments for many specific medical proceduresand tighten rules governing new technology payments.

Warnings of the dangers of isotretinoin use in pregnant women are failing, according to a report by the U.S. Centers for Disease Control and Prevention.